Allworth Financial LP acquired a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 55,023 shares of the financial services provider's stock, valued at approximately $12,151,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bridgewater Advisors Inc. acquired a new position in shares of CME Group during the second quarter worth approximately $612,000. FLC Capital Advisors acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $2,122,000. HighTower Advisors LLC increased its stake in shares of CME Group by 6.9% in the 4th quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider's stock valued at $96,376,000 after buying an additional 22,692 shares during the period. TD Private Client Wealth LLC increased its position in CME Group by 132.7% in the fourth quarter. TD Private Client Wealth LLC now owns 21,228 shares of the financial services provider's stock worth $5,797,000 after purchasing an additional 12,105 shares during the period. Finally, North Dakota State Investment Board bought a new stake in CME Group during the 4th quarter worth about $3,368,000. 87.75% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the stock. UBS Group cut their target price on shares of CME Group from $310.00 to $260.00 and set a "buy" rating on the stock in a research report on Monday, July 6th. Wall Street Zen cut shares of CME Group from a "sell" rating to a "strong sell" rating in a research report on Saturday, August 1st. The Goldman Sachs Group dropped their price target on shares of CME Group from $267.00 to $245.00 and set a "sell" rating for the company in a research note on Tuesday, June 30th. Erste Group Bank lowered shares of CME Group from a "buy" rating to a "hold" rating in a report on Friday, June 5th. Finally, Rothschild & Co Redburn raised shares of CME Group from a "neutral" rating to a "buy" rating and upped their target price for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, CME Group has a consensus rating of "Hold" and a consensus target price of $288.56.
Get Our Latest Report on CME Group
CME Group Stock Up 1.5%
NASDAQ:CME opened at $270.87 on Friday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The stock has a 50-day moving average price of $251.06 and a two-hundred day moving average price of $279.68. The stock has a market cap of $97.40 billion, a price-to-earnings ratio of 22.97, a PEG ratio of 3.11 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the firm posted $2.96 earnings per share. CME Group's revenue was up .8% compared to the same quarter last year. As a group, equities analysts expect that CME Group Inc. will post 12.27 earnings per share for the current year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is 44.11%.
Insiders Place Their Bets
In related news, Director William R. Shepard purchased 325 shares of the business's stock in a transaction on Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.